Potassium clavulanate is a β-lactamase inhibitor used in combination with β-lactam antibiotics (such as amoxicillin or ticarcillin) to enhance their antibacterial efficacy against β-lactamase-producing bacteria; it extends the antibacterial spectrum of these antibiotics and overcomes bacterial resistance; commonly used to treat infections caused by susceptible organisms including Escherichia coli, Proteus spp., Enterobacter cloacae, Haemophilus influenzae, and Streptococcus pneumoniae; indicated for skin and soft tissue infections in dogs and cats caused by β-lactamase-producing and non-producing Staphylococcus aureus, Staphylococcus spp., Streptococcus spp., E. coli, and Pasteurella spp.; also used for respiratory, gastrointestinal, and urinary tract infections in swine and poultry caused by susceptible bacteria; effective in the treatment of typhoid and paratyphoid fever; exhibits synergistic therapeutic effects in deep-seated infections such as pulmonary, intra-abdominal, and bone/joint infections.